Workflow
Qingdao Bank major shareholder change
icon
Search documents
Shell: Buybacks Make It A Hold, For Now
Seeking Alpha· 2025-06-17 19:53
Despite all the market uncertainty around Trump’s tariffs, offset now by the escalation of the Israel-Iran conflict, Shell (NYSE: SHEL ) is now back on track to reach a new all-time high fueled by significant buybacks. However, it’s these buybacksAs of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emer ...
PayPal Is Too Cheap To Ignore
Seeking Alpha· 2025-06-17 19:50
PayPal (NASDAQ: PYPL ) has experienced a big sell-off in 2021 and 2022 mainly due to lower than anticipated growth, as the company didn't manage to keep their growth rates at historical rates in the range of 15% to 21%.German Buy-Hold-Check investor. With a master's degree in engineering and management, I am able to understand, quantify, and interpret both the economics and (to some point) the technology of companies.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of th ...
Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data?
Seeking Alpha· 2025-06-17 19:42
Having taken a look at Corbus Pharmaceuticals Holdings (NASDAQ: CRBP ) and coming away cautious just after a surge in value, the stock value more than doubled over the rest of 2024 before crashingI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this ...
Stock Of The Day: Will Estee Lauder Fill The Gap?
Benzinga· 2025-06-17 19:42
The stock of The Estée Lauder Companies Inc. EL is consolidating Tuesday. This comes after the shares gained more than 10% on Monday. The move higher ended when they slammed into resistance around $74.75.Estee Lauder is our Stock of the Day. It isn't a coincidence yesterday's rally ended where it did, and the shares may be about to fill a gap.Some analysts believe the market follows a “random walk.” They believe that it is impossible to time the market.These analysts are wrong.If the market followed a rando ...
U.S. Steel Stock Burns the Bears With Surprise Upside Move
MarketBeat· 2025-06-17 19:41
United States Steel TodayXUnited States Steel$54.82 -0.03 (-0.05%) 52-Week Range$26.92▼$54.91Dividend Yield0.36%P/E Ratio36.79Price Target$43.80Add to WatchlistEvaluating the sentiment in any underlying stock is as simple as checking who is buying (and how much) and who is selling. However, seeing unusual buying or selling activity is only half the equation; the other half is up to investors to figure out whether these buyers or sellers are right in their decisions to position themselves. Reverse engineeri ...
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal
ZACKS· 2025-06-17 19:41
Key Takeaways Supernus will acquire SAGE for $8.50 per share plus CVR worth up to $3.50, totaling $795 million. The deal gives SUPN rights to Zurzuvae, the first oral postpartum depression drug, launched in late 2023. SUPN expects the acquisition to be accretive in 2026 and to broaden its neuroscience-focused portfolio.Sage Therapeutics (SAGE) announced that Supernus Pharmaceuticals (SUPN) has agreed to acquire SAGE through a tender offer of $8.50 per share in cash, totaling around $561 million. Additiona ...
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?
ZACKS· 2025-06-17 19:41
Key Takeaways Gardasil sales fell 40% in Q1 2025 due to weak demand and high inventory levels in China. MRK paused China shipments from February 2025 as Zhifei works through excess inventory. MRK withdrew Gardasil's $11B sales goal by 2030, citing China's economic headwinds.Merck’s (MRK) second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus (HPV). Though the vaccine’s sales rose consistently till 2022, it started witnessing sluggish sal ...
JetBlue CEO: More Cuts Ahead As Airline Faces Prolonged Losses
Benzinga· 2025-06-17 19:39
JetBlue Airways Corp. JBLU CEO Joanna Geraghty told employees on Tuesday that the company is rolling out additional cost-saving measures due to weaker travel demand, making it unlikely the airline will reach break-even margins this year.Financial Outlook and ProfitabilityGeraghty expressed hope that demand and bookings might improve, but noted that even a rebound would not fully recover the losses experienced so far, according to CNBC. As a result, JetBlue continues to depend on borrowed funds to maintain o ...
Meta is reportedly building AI smart glasses with Prada, too
TechCrunch· 2025-06-17 19:38
In Brief Meta is working on a pair of AI smart glasses with the Italian high fashion brand, Prada, according to a report from CNBC on Tuesday. It’s unclear at this time when Meta’s Prada smart glasses will be publicly announced.The reported Prada collaboration signifies that Meta aims to bring its AI smart glasses technology to more fashion companies outside of its relationship with eyewear giant EssilorLuxottica. Until now, Meta has collaborated closely with EssilorLuxottica and its numerous brands. Prada ...
Keep an Eye on This Chip Stock Next Week
Schaeffers Investment Research· 2025-06-17 19:37
Earnings season is mostly over, but next week one report will capture investor attention. Chipmaker Micron Technology Inc (NASDAQ:MU) reports fiscal second-quarter earnings after the market closes on Wednesday, July 25. Ahead of the event, options traders are betting bullishly. Micron has a history of making volatile post-earnings moves. Looking back at its past eight reports shows MU ending five of these next-day sessions lower, including a bear gap of 8% in March and 16.2% in December. The security has av ...